Showing 801 - 820 results of 2,736 for search '"alcoholism"', query time: 0.05s Refine Results
  1. 801
  2. 802
  3. 803
  4. 804
  5. 805
  6. 806
  7. 807
  8. 808
  9. 809
  10. 810
  11. 811

    Prebiotic Properties and High-Density Culture of Bifidobacterium longum B2-01, a Strain Isolated from the Intestinal Tract of Infants by PENG Yunyan, ZHONG Shuying, LIU Dongmei, XU Xilin

    Published 2025-01-01
    Subjects: “…bifidobacterium longum; infant intestine; antioxidant activity; protection against alcoholic liver; high-density culture…”
    Get full text
    Article
  12. 812
  13. 813
  14. 814
  15. 815
  16. 816
  17. 817

    Improved Electrochemical Performance of Li1.25Ni0.2Co0.333Fe0.133Mn0.333O2 Cathode Material Synthesized by the Polyvinyl Alcohol Auxiliary Sol-Gel Process for Lithium-Ion Batteries by He Wang, Mingning Chang, Yonglei Zheng, Ningning Li, Siheng Chen, Yong Wan, Feng Yuan, Weiquan Shao, Sheng Xu

    Published 2018-01-01
    “…A lithium-rich manganese-based cathode material, Li1.25Ni0.2Co0.333Fe0.133Mn0.333O2, was prepared using a polyvinyl alcohol (PVA)-auxiliary sol-gel process using MnO2 as a template. …”
    Get full text
    Article
  18. 818

    Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12) by V. T. Ivashkin, I. G. Bakulin, P. O. Bogomolov, M. V. Matsiyevich, N. I. Geyvandova, P. V. Koroy, S. V. Nedogoda, O. A. Sablin, L. G. Lenskaya, Ye. V. Beloborodova, A. A. Bagretsova, R. A. Abdulkhakov, M. F. Osipenko, I. V. Osipova, D. A. Pocheptsov, Ye. V. Chumachek, O. M. Khromtsova, Ye. V. Kuzmicheva

    Published 2018-08-01
    “…To estimate efficacy and safety of two pharmacological forms of «Phosphogliv» (lyophilizate for intravenous administration and capsules) for the treatment of fatty liver degeneration of non-alcoholic etiology. Material and methods. Original study included overall 180 patients with nonalcoholic fatty liver disease that were randomized to the basic and control groups in the ratio of 2:1. …”
    Get full text
    Article
  19. 819
  20. 820